DCVMN Training Workshop- Global registration...

Documents

• bionet_ap_dcvmn_mar2017_publish.pdf (PDF - 2 Mb)
• bio_farma_presentation_in_taipei_march_2017_.pdf (PDF - 2.2 Mb)
• challenges_for_registration_of_vaccines-2.pdf (PDF - 1.2 Mb)
• challenges_for_registration_of_vaccines.pdf (PDF - 1006.1 kb)
• collaborations.pdf (PDF - 1.6 Mb)
• dcvmn_taipei_paologolfetto_170306_vhandout.pdf (PDF - 1.7 Mb)
• ge_healthcare_dcvmn_introduction_to_pd_for_vaccine_production_29256323aa_10m (...) (PDF - 1.9 Mb)
• ge_healthcare_dcvmn_process_economy_for_vaccines_29256324aa_10mar2017.pdf (PDF - 2.7 Mb)
• ge_healthcare_dcvmn_qbd_in_process_development_incl_exercise_29256324aa_10ma (...) (PDF - 880.2 kb)
• ge_healthcare_dcvmn_vaccine_downstream_processin_an_overview_29256326aa_10ma (...) (PDF - 679.4 kb)
• ge_healthcare_dcvmn_vaccine_upstream_processing_an_overview_10mar2017.pdf (PDF - 2.6 Mb)
• global_overview_of_registration.pdf (PDF - 1.5 Mb)
• immunogenicity_and_safety_of_an_e._coli-produced_bivalent_human_papillomavir (...) (PDF - 1012.4 kb)
• international_procurement_and_supply_schemes_part_1.pdf (PDF - 3 Mb)
• international_procurement_and_supply_schemes_part_2.pdf (PDF - 2.2 Mb)
• regulatory_framework_of_vaccines_in_taiwan.pdf (PDF - 13.2 Mb)
• safety_and_immunogenicity_of_a_combined_tetanus_diphtheria_recombinant_acell (...) (PDF - 1.2 Mb)
• siipl_bcg.pdf (PDF - 2.9 Mb)
• siipl_mcv.pdf (PDF - 10.2 Mb)
• sipv-taipei.pdf (PDF - 8.9 Mb)
• supply_and_shortages.pdf (PDF - 1 Mb)
• taipei_workshop_agenda_01.03.17.pdf (PDF - 240 kb)
• test_1_correct_answers.pdf (PDF - 79.4 kb)
• vvm-en-2017_0305taipei.pdf (PDF - 3.9 Mb)